Process and Product Development Subcommittee

Charter

The Process and Product Development Subcommittee strives to:

  • Establish and communicate best practices in Process and Product Development (PPD) as it relates to therapeutic cell based products.
  • Assess emerging cell processing technologies and forecast their impact on the commercialization process.

Click here to view the full charter.

Projects and Objectives

  • Educational Webinars: Process Development is a discipline learned on the job and there are few texts that cover many of the best practices used in the field—and fewer available that discuss Cell Therapy-specific requirements. The Process and Product Development Subcommittee develops educational webinars to cover best practices in Cell Therapy Process Development. Click here to view upcoming webinars.
  • White papers: White papers are an important vehicle for the PPD to educate and influence the field. White papers will be published in peer-reviewed journals to increase credibility and visibility of the PPD and ISCT. Click here to view the published PPD white papers.
  • ISCT Annual Meeting: The PPD will be actively involved in the organization of the ISCT Annual Meeting. At least one session in the Strategies for Commercialization Track will be organized by this committee.

 

 


 

Committee Chair

 



Dominic Clarke, PhD
Co-Chair
HemaCare
Winston Salem, NC, United States

John Fink, MBA
Co-Chair
Pall Corporation
Boston, MA, United States

 

Committee Members

 

Sasha Aleksic, MSc
FUJIFILM Irvine Scientific
Irvine, CA, United States

Julie Allickson, PhD, MSc, MT(ASCP)
Wake Forest Institute for Regenerative Medicine
Winston-Salem, NC, United States


 
Hyalker Amaral, MBA
Terumo BCT
Denver, CO, United States
Behnam Ahmadian Baghbaderani, PhD
Lonza Walkersville
Walkersville, MD, United States
  
Harvey Brandwein, PhD
Cook Myosite
New York, NY, United States
Christopher Bravery, PhD
Advanced Biologicals Ltd.
London, United Kingdom
   
Soenke Brunswieck, PhD
Celonic AG
Basel, Switzerland

Scott Burger, MD
Advanced Cell & Gene Therapy
Chapel Hill, NC, United States

   
Shannon Eaker, PhD
Cytiva 
Knoxville, TN, United States

David Fiorentini, MSc
Biological Industries
Beit-Haemek, Israel

   
Maya Fuerstenau-Sharp, PhD
Sartorius-Stedim Biotech
Gottingen, Germany

Clive Glover, PhD
Pall Life Sciences
Portsmouth, United Kingdom

   

Heidi Hagen, MS, MBA
Vineti
Seattle, WA, United States

Jack Hench
Cytiva
Durham, NC, United States
   
Robert Jones
Cryoport
London, United Kingdom
Ohad Karnieli, PhD, MBA
Adva Biotechnology
Haifa, Israel
   
Christopher Keller
Celularity
Warren, NJ, United States

Julie Kerby, PhD
Cell & Gene Therapy Catapult
London, United Kingdom

   

Alex Lyness, PhD
West Pharmaceutical Services
Exton,PA, United States

Mark Leonard
Allogene
San Francisco, CA, United States
   
Kara Levine, PhD
MilliporeSigma
Bedford, MA, United States
Lexan Lhu, MSc
PBS Biotech
Cambridge, MA, United States
   
Yonatan Lipsitz, PhD
Sana Therapeutics 
Boston, MA, United States
Michael Mendicino, PhD
Hybrid Concepts International, LLC
Grand Island, NY, United States

   
Grace O'Connell, PhD
UC Berkeley
Berkely, CA, United States
Steve Oh, PhD
ASTAR
Singapore
   
Jean-Sébastien Parisse, MBA
Aseptic Technologies
Gembloux, Belgium
Shabnum Patel, PhD
Stanford University, Center for Cancer Cell Therapy
Stanford, CA, United States
   
Ulrike Rehn, PhD
Thermo Fisher Scientific
Buffalo, NY, United States
Janet Rothberg
CCRM
Toronto, ON, Canada
   
Alaina Schlinker, PhD
Fresenius-Kabi
Lake Zurich, IL, United States

Michael Scott, PhD
BlueRock Therapeutics
Toronto, ON, Canada

   
Robert Sassa
WL Gore & Associates
Exton, MD, United States

David Smith, PhD
Hitachi Chemical Advanced Therapeutic Solutions (HCATS)
Allendale, NJ, United States

 


  
 
  

 


Jean-Sébastien Parisse
Asceptic Technologies
Isnes, Belgium

© 2020 ISCT. All rights reserved. 
ISCT, INTERNATIONAL SOCIETY FOR CELLULAR THERAPY and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy